The Effect of Dietary Glutathione and Coenzyme Q10 on the Prevention and Treatment of Inflammatory Bowel Disease in Mice

International Journal for Vitamin and Nutrition Research

Volumn 74, Issue 1, 2004, Pages 74-85

  Liu, Chun ^a   Russell, Robert M ^a   Smith, Donald E ^a   Bronson, Roderick T ^a   Milbury, Paul E ^a   Furukawa, Satoru ^b   Wang, Xiang Dong ^a   Blumberg, Jeffrey B ^a  

^a TUFTS UNIVERSITY   (United States)

^b Nutri Quest Inc   (United States)

Author keywords

Coenzyme Q; Colitis; Dextran sulfate sodium; Glutathione; Inflammatory bowel disease; Mice

Indexed keywords

DEXTRAN SULFATE; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; UBIDECARENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; COLON ULCER; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DYSPLASIA; ENTERITIS; FEMALE; HISTOLOGY; MOUSE; NONHUMAN; OCCULT BLOOD; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RISK BENEFIT ANALYSIS;

ANIMALIA;

EID: 1542344539     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.74.1.74     Document Type: Article

References (43)

1. Karlinger, K., Györke, T., Makö, E., Mester, A., and Tarján, Z. (2000) The epidemiology and the pathogenesis of inflammatory bowel disease. Eur. J. Radiol. 35, 154-167.
2. Panés, J. (2001) Inflammatory bowel disease: pathogenesis and targets for therapeutic interventions. Acta Physiol. Scand. 173, 159-165.
3. Harris, M. L., Schiller, H. J., Reilly, P. M., Donowitz, M., Grisham, M. B., and Bulkley, G. B. (1992) Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? Pharmacol. Ther. 53, 375-408.
4. Gross, V., Arndt, H., Andus, T., Palitzsch, K. D., and Scholmerich, J. (1994) Free radicals in inflammatory bowel diseases pathophysiology and therapeutic implications. Hepatogastroenterology 41, 320-327.
5. Keshavarzian, A., Sedghi, S., Kanofsky, J., List, T., Robinson, C., Ibrahim, C., and Winship, D. (1992) Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 103, 177-185.
6. Sedghi, S., Fields, J. Z., Klamut, M., Urban, G., Durkin, M., Winship, D., Fretland, D., Olyaee, M., and Keshavarzian, A. (1993) Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis. Gut 34, 1191-1197.
7. Bhaskar, L., Ramakrishna, B. S., and Balasubramanian, K. A. (1995) Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis. J. Gastroenterol. Hepatol. 10, 140-143.
8. Melichar, B., Karlicek, R., and Tichy, M. (1994) Increased urinary nitrate excretion in inflammatory bowel disease. Eur. J. Clin. Chem. Clin. Biochem. 32, 3-4.
9. Simmonds, N. J., Allen, R. E., Stevens, T. R., Van Someren, R. N., Blake, D. R., and Rampton, D. S. (1992) Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 103, 186-196.
10. Boughton-Smith, N. K., Evans, S. M., Hawkey, C. J., Cole, A. T., Balsitis, M., Whittle, B. J., and Moncada, S. (1993) Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 342, 338-340.
11. Phylactos, A. C., Fasoula, I. N., Arnaud-Battandier, F., Walker-Smith, J. A., and Fell, J. M. (2001) Effect of entail nutrition on antioxidant enzyme systems and inflammation in paediatric Crohn's disease. Acta Paediatr. 90, 883-888.
12. Durak, I., Yasa, M. H., Bektas, A., Kacmaz, M., Cimen, M. Y., and Ozturk, H. S. (2000) Mucosal antioxidant defense is not impaired in ulcerative colitis. Hepatogastroenterology 47, 1015-1017.
13. White, A. C., Thannickal, V. J., and Fanburg, B. L. (1994) Glutathione deficiency in human disease. J. Nutr. Biochem. 5, 218-226.
14. Hagen, T. M., Wierzbicka, G. T., Bowman, B. B., Aw, T. Y., and Jones, D. P. (1990) Fate of dietary glutathione: disposition in the gastrointestinal tract. Am. J. Physiol. 259, G530-535.
15. Moldéus, P., and Jerström, B. (1983) in Functions of glutathione: Biochemical, physiological, toxicological, and clinical aspects (Larssin, A., Orrenius, S., Holmgren, A., and Mannervik, B., Eds.), pp. 99-108. Raven Press, New York.
16. Exner, R., Wessner, B., Manhart, N., and Roth, E. (2000) Therapeutic potential of glutathione. Wien Klin. Wochenschr. 112, 610-616.
17. Ruan, E. A., Rao, S., Burdick, J. S., Stryker, S. J., Telford, G. L., Otterson, M. F., Opara, E. C., and Koch, T. R. (1997) Glutathione levels in chronic inflammatory disorders of the human colon. Nutr. Res. 17, 463-473.
18. Miralles-Barrachina, O., Savoye, G., Belmonte-Zalar, L., Hochain, P., Ducrotte, P., Hecketsweiler, B., Lerebours, E., and Dechelotte, P. (1999) Low levels of glutathione in endoscopic biopsies of patients with Crohn's colitis: the role of malnutrition. Clin. Nutr. 18, 313-317.
19. Buffinton, G. D., and Doe, W. F. (1995) Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radic. Biol. Med. 19, 911-918.
20. Hoffenberg, E. J., Deutsch, J., Smith, S., and Sokol, R. J. (1997) Circulating antioxidant concentrations in children with inflammatory bowel disease. Am. J. Clin. Nutr. 65, 1482-1488.
21. Ernster, L., and Dallner, G. (1995) Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1271, 195-204.
22. Beyer, R. E. (1990) The participation of coenzyme Q in free radical production and antioxidation. Free Radic. Biol. Med. 8, 545-565.
23. Beyer, R. E. (1992) An analysis of the role of coenzyme Q in free radical generation and as an antioxidant. Biochem. Cell Biol. 70, 390-403.
24. Beyer, R. E. (1994) The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q. J. Bioenerg. Biomembr. 26, 349-358.
25. Binder, V. (1968) Histochemical studies of the colonic mucosa in ulcerative colitis and other colonic diseases. Scand. J. Gastroenterol. 3, 611-621.
26. Elson, C. O., Sartor, R. B., Tennyson, G. S., and Riddell, R. H. (1995) Experimental models of inflammatory bowel disease. Gastroenterology 109, 1344-1367.
27. Warren, B. F., and Watkins, P. E. (1994) Animal models of inflammatory bowel disease. J. Pathol. 172, 313-316.
28. Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., and Nakaya, R. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694-702.
29. Cooper, H. S., Murthy, S. N., Shah, R. S., and Sedergran, D. J. (1993) Clinicopathologic study of dextran sulfate sodium experimental mourn colitis. Lab. Invest. 69, 238-249.
30. Reeves, P. G., Nielsen, F. H., and Fahey, G. C., Jr. (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123, 1939-1951.
31. Furukawa, T., Meydani, S. N., and Blumberg, J. B. (1987) Reversal of age-associated decline in immune responsiveness by dietary glutathione supplementation in mice. Mech. Ageing Dev. 38, 107-117.
32. Beal, M. F. (1999) Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases. Biofactors 9, 261-266.
33. Williams, K. D., Maneke, J. D., AbdelHameed, M., Hall, R. L., Palmer, T. E., Kitano, M., and Hidaka, T. (1999) 52-week oral gavage chronic toxicity study with ubiquinone in rats with a 4-week recovery. J. Agric. Food Chem. 47, 3756-3763.
34. Richie, J. P., and Lang C. A. (1987) The determination of glutathione, Cyst(e)ine, and other thiols and disulfides in biological samples using high-performance liquid chromatography with dual electrochemical detection. Anal. Biochem. 163, 9-15.
35. Lang, J. K., Gohil, K., and Packer, L. (1986) Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal. Biochem. 157, 106-116.
36. Takada, M., Ikenoya, S., Yuzuriha, T., and Katayama, K. (1984) Simultaneous determination of reduced and oxidized ubiquinones. Methods Enzymol. 105, 147-155.
37. Wiechelman, K., Braun, R. and Fitzpatrick, J. (1988). Investigation of the bicinchoninic acid protein assay identification of the groups responsible for color formation. Anal. Biochem. 175, 231-237.
38. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
39. Bistrian, B. R., and Walker-Smith, J. A., Eds. (1999) Inflammatory Bowel Diseases, Nestlé Nutrition Workshop Series.
40. Reimund, J. M., Hirth, C., Koehl, C., Baumann, R., and Duclos, B. (2000) Antioxidant and immune status in active Crohn's disease. A possible relationship. Clin. Nutr. 19, 43-48.
41. Koch, T. R., Yuan, L. X., Fink, J. G., Petro, A., and Opara, E. C. (2000) Induction of enlarged intestinal lymphoid aggregates during acute glutathione depletion in a mourn model. Dig. Dis. Sci. 45, 2115-2121.
42. Ardite, E., Sans, M., Panes, J., Romero, F. J., Pique, J. M., and Fernandez-Checa, J. C. (2000) Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab. Invest. 80, 735-744.
43. Elson, C. O., Cong, Y., and Sundberg, J. (2000) The C3H/HeJBir mouse model: a high susceptibility phenotype for colitis. Int. Rev. Immunol. 19, 63-75.